Our results are consistent with those obtained in other brain injuries such as hypoxic/ischemic brain injury [28] and Alzheimer’s disease [29], in which the tight junction proteins claudin-V, occludin, and ZO-1 have demonstrated a role as promising biomarkers for cerebrovascular dysfunction. Here, OCLN is linked to early-onset autosomal dominant Alzheimer disease.